Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma

Figure 1 ARID1A protein expression in intrahepatic cholangiocarcinoma patients. Western blotting for ARID1A expression in intrahepatic cholangiocarcinoma tissues, paracarcinomatous tissues, and normal liver tissues. GAPDH was used as the internal loading control. IHCC: Intrahepatic cholangiocarcinoma; PC: Paracarcinomatous; NL: Normal liver.

Figure 2 ARID1A mRNA level in intrahepatic cholangiocarcinoma patients. IHCC: Intrahepatic cholangiocarcinoma; PC: Paracarcinomatous; NL: Normal liver. ^cP < 0.001 vs PC and NL.

Figure 3 Overall survival (A) and disease-free survival (B) of patients with intrahepatic cholangiocarcinoma after surgical resection according to ARID1A protein expression in intrahepatic cholangiocarcinoma tissues (P < 0. 01; log-rank test).